A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients
Crossref DOI link: https://doi.org/10.1007/s40262-016-0414-3
Published Online: 2016-06-14
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Erp, Nielka P.
van Herpen, Carla M.
de Wit, Djoeke
Willemsen, Annelieke
Burger, David M.
Huitema, Alwin D. R.
Kapiteijn, Ellen
ter Heine, Rob
Funding for this research was provided by:
Novartis Pharma
License valid from 2016-06-14